JOHN G ULLMAN & ASSOCIATES INC JAZZ JAZZ PHARMACEUTICALS ORD

Ownership history in JOHN G ULLMAN & ASSOCIATES INC  ·  9 quarters on record

AI Ownership Summary

JOHN G ULLMAN & ASSOCIATES INC reported JAZZ PHARMACEUTICALS ORD (JAZZ) in 9 quarterly 13F filings from 2024 Q1 through 2026 Q1. Peak portfolio weight reached 0.92% in 2024 Q2. The latest visible filing shows JAZZ at 0.82% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this JAZZ ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was JOHN G ULLMAN & ASSOCIATES INC's position in JAZZ PHARMACEUTICALS ORD, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

JAZZ was reported at 0.82% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.92% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How JOHN G ULLMAN & ASSOCIATES INC held JAZZ — position size vs. price
% of Fund (quarterly)    JAZZ price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 32,833 -1,567 -4.6% 0.82% $6.2M 2026-05-06 $228.57
2025 Q4 REDUCED 34,400 -975 -2.8% 0.78% $5.8M 2026-02-05 $163.15
2025 Q3 REDUCED 35,375 -535 -1.5% 0.63% $4.7M 2025-11-05 $137.22
2025 Q2 REDUCED 8.2% +21.6% 35,910 -3,208 -8.2% 0.57% $3.8M 2025-07-29 $116.60
2025 Q1 REDUCED 39,118 -632 -1.6% 0.75% $4.9M 2025-05-06 $111.17
2024 Q4 REDUCED 11.9% +0.8% 39,750 -5,344 -11.9% 0.72% $4.9M 2025-02-05 $121.53
2024 Q3 REDUCED 20.2% +10.4% 45,094 -11,400 -20.2% 0.72% $5.0M 2024-11-08 $123.61
2024 Q2 ADDED 56,494 +26,344 +87.4% 0.92% $6.0M 2024-08-08 $112.97
2024 Q1 INITIATED 30,150 0.56% $3.6M 2024-05-06 $109.85

FAQ About JOHN G ULLMAN & ASSOCIATES INC and JAZZ

These are the practical questions this page is built to answer before you even open the full history table.

How long has JOHN G ULLMAN & ASSOCIATES INC reported owning JAZZ?

JOHN G ULLMAN & ASSOCIATES INC reported JAZZ across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported JAZZ position in JOHN G ULLMAN & ASSOCIATES INC's portfolio?

The largest reported portfolio weight for JAZZ was 0.92% in 2024 Q2.

What is the latest reported JAZZ position on this page?

The most recent filing on this page is 2026 Q1, when JOHN G ULLMAN & ASSOCIATES INC reported 32,833 shares, equal to 0.82% of portfolio, with an estimated market value of $6.2M.

What does the chart on this JAZZ ownership page compare?

The chart compares JOHN G ULLMAN & ASSOCIATES INC's quarterly JAZZ portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did JOHN G ULLMAN & ASSOCIATES INC time their JAZZ position?

Based on 13F filing dates vs. subsequent JAZZ price moves, JOHN G ULLMAN & ASSOCIATES INC correctly timed 4 out of 8 reported position changes (50%). The annualised alpha on JAZZ relative to SPY over the holding period was +19.6%.

← Back to JOHN G ULLMAN & ASSOCIATES INC Holdings